lung cancer
Conditions
Interventions
Experimental group:Dexmedetomidine combined with dezocine
Control group:General anesthesia
Sponsors
Fudan University Cancer Hospital
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Endoscopic lung tumor patients who signed informed consent; 2. Aged >= 50 years; 3. The ASA rating of the American Society of Anesthesiologists is Class I to II; 4. New York College of Cardiology (NYHA) Heart function Classification I to II; 5. Child-Pugh grade A and B.
Exclusion criteria
Exclusion criteria: 1. BMI40kg/m2 2. Patients with preoperative impairment of consciousness and cognitive function; 3. Coronary heart disease, serious arrhythmia, cardiopulmonary dysfunction, cerebrovascular accident; 4. Anemia patients; 5. High blood sugar; 6. Patients with liver and kidney dysfunction; 7. Patients with asthma, COPD, or pulmonary function examination indicating moderate or above ventilatory dysfunction; 8. Speech, and audiovisual dysfunction.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inflammatory factor;Cognitive function assessment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Arterial blood gas analysis during and after operation;Length of stay;Postoperation pain;Nausea and vomiting;Time of operation;Duration of mechanical ventilation;Length of stay in PACU;Procedure-related adverse events; | — |
Countries
China
Contacts
Public ContactJun Zhang
Fudan University Cancer Hospital
Outcome results
None listed